Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Safusidenib by AnHeart Therapeutics for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Safusidenib is under clinical development by AnHeart Therapeutics and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...
Data Insights
Safusidenib by AnHeart Therapeutics for Solid Tumor: Likelihood of Approval
Safusidenib is under clinical development by AnHeart Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...